Taunia Markvicka

Taunia has over 25 years of pharmaceutical experience from regulatory/clinical to new product planning and commercialization. Taunia was previously Chief Operating Officer (US) for PolyPid (PYPD) where she was integral in the successful company IPO. Prior, she was Chief Commercial Officer (CCO) at Symbiomix Therapeutics, a venture funded company, sold to Lupin Pharmaceuticals. She was also CCO at Pacira Bioscience (PCRX), taking the company public and successfully launching EXPAREL®. Prior to Pacira, Taunia held commercial leadership positions with Advantage Healthcare, The Medicines Company, and Allergan (formerly Watson). She started her career as a hospital pharmacist and joined the pharmaceutical industry following the completion of a post-doctorate fellowship with Novartis (former Sandoz Pharmaceuticals). Taunia has over 25 years of pharmaceutical experience successfully acquiring companies, technologies, and commercializing products.

Taunia earned her doctorate in pharmacy from the University of Nebraska Medical Center and post-doctoral fellowship with Rutgers University/Sandoz Pharmaceuticals, after completing her Bachelors, Pharmacy at Creighton and becoming a registered pharmacist. She went on to complete her master’s in business administration at St. Joseph’s University.